Search Results - Yusuke Inoue

  • Showing 1 - 5 results of 5
Refine Results
  1. 1

    Knockout of the mitoribosome rescue factors Ict1 or Mtrfr is viable in zebrafish but not mice: compensatory mechanisms underlying each factor's loss by Nobukazu Nameki, Chika Tomisawa, Soichiro Hoshino, Hidehiko Shimizu, Masashi Abe, Sho Arai, Kanako Kuwasako, Naoki Asakawa, Yusuke Inoue, Takuro Horii, Izuho Hatada, Masakatsu Watanabe

    Published 2025-08-01

    The mitochondrial translation system contains two ribosome rescue factors, ICT1 and MTRFR (C12orf65), which hydrolyze peptidyl‐tRNA in stalled ribosomes. ICT1 also functions as a ribosomal protein of the mitochondrial large ribosomal subunit (mtLSU) in mice and humans, and its deletion is lethal. In...

    Full description

    Get full text
    Article
  2. 2

    Severe drug-induced interstitial lung disease after photoimmunotherapy with cetuximab–sarotalocan sodium in a patient with oropharyngeal cancer: A case report by Sho Takuma, Masato Karayama, Risa Suzuki, Koichi Miyashita, Yusuke Inoue, Hideki Yasui, Hironao Hozumi, Yuzo Suzuki, Kazuki Furuhashi, Noriyuki Enomoto, Tomoyuki Fujisawa, Naoki Inui, Takafumi Suda

    Published 2025-01-01

    Background: Photoimmunotherapy (PIT) using cetuximab–sarotalocan sodium (CS) is a novel therapy for unresectable or locally recurrent head and neck squamous cell carcinoma (HNSCC). CS is a conjugate of cetuximab (monoclonal antibody targeting epidermal growth factor receptor [EGFR]) and IR700 (light...

    Full description

    Get full text
    Article
  3. 3

    First-line durvalumab plus platinum–etoposide in Japanese patients with extensive-stage small-cell lung cancer by Eisuke Mochizuki, Shun Matsuura, Naoki Koshimizu, Suguru Kojima, Shogo Sakurai, Satoshi Kishimoto, Mitsuru Niwa, Masayuki Watanuki, Ryunosuke Inaba, Sho Takuma, Yusuke Inoue, Masato Karayama, Naoki Inui, Takafumi Suda

    Published 2025-01-01

    Background: Platinum-based chemotherapy combined with immune checkpoint inhibitor therapy has recently been introduced for treating extensive-stage small-cell lung cancer (ES-SCLC). In the Phase III CASPIAN study, first-line etoposide (Etoposide) with cisplatin / carboplatin (EP) plus durvalumab sig...

    Full description

    Get full text
    Article
  4. 4

    Alveolar Sarcoidosis Mimicking Idiopathic Interstitial Pneumonia Without Mediastinal Lymphadenopathy by Hiroki Kanasaki, Noriyuki Enomoto, Yuko Tanaka, Suguru Kojima, Keisuke Morikawa, Shogo Nakai, Shusuke Yazawa, Yasutaka Mochizuka, Yusuke Inoue, Hideki Yasui, Hironao Hozumi, Yuzo Suzuki, Masato Karayama, Kazuki Furuhashi, Tomoyuki Fujisawa, Naoki Inui, Sayaka Ishigaki, Naro Ohashi, Yasunori Enomoto, Satoshi Baba, Kazuhiro Tabata, Takeshi Johkoh, Takafumi Suda

    Published 2025-07-01

    ABSTRACT We present a case of alveolar sarcoidosis showing lower lobe‐predominant areas of airspace consolidation and ground‐glass attenuation on HRCT, mimicking idiopathic interstitial pneumonia (IIP) with spontaneous wandering. Mediastinal lymphadenopathy and uveitis were negative. Surgical lung b...

    Full description

    Get full text
    Article
  5. 5